BioSpace News Archive

EOC Pharma Completed Series B Financing From Leading Global Investors

EOC Pharma Group today announced that it has completed a $32 million Series B financing led by Taikang Investment through Shandong State-owned Taikang Industry Development Fund (Taikang).

November 7, 2017

·

3 min read

Genetown

Seres Therapeutics Awarded Grant From CARB-X to Support Development of Microbiome Therapeutic Candidate

The CARB-X grant provides Seres with up to $2.5 million of research funding with potential for an additional $3.1 million upon completion of milestones.

November 7, 2017

·

6 min read

Business

Acerus Reports Third Quarter 2017 Financial Results

Product revenue for Q3 2017 grew to $1.6 million versus $1.4 million for Q3 2016 mainly due to increased sales of Natesto®.

November 7, 2017

·

10 min read

Drug Development

Alnylam Initiates ENVISION Phase III Clinical Study with Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias (AHPs)

It intends to file a New Drug Application (NDA) for givosiran at or around year-end 2018.

November 7, 2017

·

11 min read

Biotech Bay

Aradigm to Host Key Opinion Leader Meeting and Webcast on November 9 in New York City

Aradigm announced today that it will host a Key Opinion Leader (KOL) Breakfast on the topic of Non-Cystic Fibrosis Bronchiectasis (NCFBE) on Thursday, November 9, 2017 from 8:00-9:30 am Eastern Time in New York, NY.

November 7, 2017

·

4 min read

Abbott Deals and Med Device Pipeline Fuel Growth i

Job Trends

Bay Area’s Oyster Point Pharma Emerges With $22M, One Employee and Plans to Hire

Oyster Point Pharma announced the close of a Series A financing worth $22M.

November 7, 2017

·

2 min read

Drug Development

International Study at MD Anderson Sister Institutions Supports Mino Lok Phase IIb Results: Poster Presented at ID Week

The 44 patient study, was conducted in Brazil, Lebanon, and Japan and showed Mino Lok therapy was an effective intervention to salvage long term, infected CVCs in catheter related bloodstream infections in patients who had cancer with limited vascular access.

November 7, 2017

·

4 min read

Drug Development

Janssen’s New Phase II Data Show Treatment With TREMFYA (guselkumab) Improved Psoriatic Arthritis Symptoms Through One Year

According to findings presented at the 2017 ACR/ARHP Annual Meeting, more than 70 percent of patients receiving TREMFYA 100 mg subcutaneous injections achieved at least a 20 percent improvement in signs and symptoms of disease using observed data at week 56.

November 7, 2017

·

11 min read

Business

Cardiome to Hold Third Quarter 2017 Financial Results Conference Call on November 14

Cardiome will hold a conference call and webcast at 4:30 p.m. Eastern on that day to discuss the results.

November 7, 2017

·

5 min read

Business

Infinity Provides Company Update and Reports Third Quarter 2017 Financial Results

n August, Infinity announced that the company designated the 60 mg QD dose for evaluation in the monotherapy expansion component of the study, which is now under way.

November 7, 2017

·

19 min read